Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Debt / NOTE 3.000% 6/0
-
Number of holders
-
24
-
Total principal
-
134M
-
Principal change
-
+3.57M
-
Total reported value, excl. options
-
$160M
-
Value change
-
+$11.9M
-
Number of buys
-
13
-
Number of sells
-
-13
-
Price
-
$1.18
Significant Holders of ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q3 2016
24 filings reported holding 04269XAA3 - ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 as of Q3 2016.
ARRAY BIOPHARMA INC - NOTE 3.000% 6/0 has 24 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $134M of principal
.
Largest 10 bondholders include DEERFIELD MANAGEMENT CO ($45M of principal), OAKTREE CAPITAL MANAGEMENT LP ($19.6M of principal), WOLVERINE ASSET MANAGEMENT LLC ($11.1M of principal), CSS LLC/IL ($10.5M of principal), CITADEL ADVISORS LLC ($10.3M of principal), TENOR CAPITAL MANAGEMENT Co., L.P. ($5M of principal), UBS OCONNOR LLC ($5M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($4.75M of principal), Redmile Group, LLC ($4M of principal), and Verition Fund Management LLC ($3.4M of principal).
This table shows the top 24 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.